Evidence map›Paper›PMID 37560464›Full record

ArticleFrontiers in oncology2023

Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy.

Victoria M Valvo, Emanuele Vitale, Marco Tigano, Rachel Evans, Meredith A Morgan, Qiang Zhang

Erratum issuedAbstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Victoria M ValvoDepartment of Radiation Oncology, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, United States.
Emanuele VitaleLaboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Marco TiganoMitoCare Center, Department of Pathology and Genomic Medicine, Thomas Jefferson University, Philadelphia, PA, United States.
Rachel EvansRichard Dimbleby Department of Cancer Research, Randall Division & Division of Cancer Studies, Kings College London, London, United Kingdom.
Meredith A MorganDepartment of Radiation Oncology, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, United States.
Qiang ZhangDepartment of Radiation Oncology, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, United States.

Funding

Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancerR01CA240515 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MORGAN, MEREDITH A · 2020 to 2024
$2.2M
From mtDNA stress to cellular immunity: Triggers, Mechanisms and EffectorsR35GM147191 · NIGMS · THOMAS JEFFERSON UNIVERSITY · PI Marco Tigano · 2022 to 2026
$2.2M
NCI NIH HHS R01 CA240515NIGMS NIH HHS R35 GM147191
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DNA damage responseimmunotherapyinnate immunityradiotherapytumor microenvironment

Identifiers

PMID37560464
PMCPMC10408123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.